UCP2 and type 2 diabetes mellitus: These studies, including our present and previous data (Zhang et al., 2022; Zhang et al., 2023) make a strong argument that restoring UCP2 expression may serve as a potential therapeutic strategy for improving T2DM-induced CVP neuronal dysfunction.